Page last updated: 2024-08-21

violacein and Leukemia

violacein has been researched along with Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diks, SH; Duran, N; Ferreira, CV; Fuhler, GM; Justo, GZ; Milani, R; Peppelenbosch, MP; Queiroz, KC; Ruela-de-Sousa, RR; Spek, CA; Zambuzzi, WF1
Justo, GZ; Miranda, A; Nogueira-Pedro, A; Paredes-Gamero, EJ1

Reviews

1 review(s) available for violacein and Leukemia

ArticleYear
Hematopoietic modulators as potential agents for the treatment of leukemia.
    Frontiers in bioscience (Elite edition), 2013, 01-01, Volume: 5, Issue:1

    Topics: Antimicrobial Cationic Peptides; Biological Factors; Depsipeptides; Free Radicals; Hematopoiesis; Hematopoietic System; Humans; Indoles; Leukemia; Receptors, Purinergic P2; Shikimic Acid; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2013

Other Studies

1 other study(ies) available for violacein and Leukemia

ArticleYear
Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Calpain; Cell Death; Cell Line, Tumor; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Death-Associated Protein Kinases; Endoplasmic Reticulum Stress; Golgi Apparatus; Humans; Indoles; Leukemia; Proto-Oncogene Proteins c-akt

2012